Pharmaron Beijing Co., Ltd. (HKG:3759)
Hong Kong · Delayed Price · Currency is HKD 28.44
+1.56 (5.80%)
Sep 30, 2025, 4:08 PM HKT
Pharmaron Beijing Market Cap
Pharmaron Beijing has a market cap or net worth of 66.06 billion as of September 30, 2025. Its market cap has increased by 93.02% in one year.
Market Cap
66.06B
Enterprise Value
70.27B
Revenue
14.37B
Ranking
n/a
PE Ratio
43.65
Stock Price
28.44
Market Cap Chart
Since January 28, 2019, Pharmaron Beijing's market cap has increased from 8.42B to 66.06B, an increase of 684.48%. That is a compound annual growth rate of 36.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 66.06B | 48.36% |
| Dec 31, 2024 | 44.53B | -14.67% |
| Dec 29, 2023 | 52.19B | -40.01% |
| Dec 30, 2022 | 86.99B | -33.39% |
| Dec 31, 2021 | 130.60B | 16.63% |
| Dec 31, 2020 | 111.98B | 155.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 279.26B |
| Hansoh Pharmaceutical Group Company | 210.92B |
| JD Health International | 206.50B |
| Innovent Biologics | 159.71B |
| WuXi Biologics | 158.73B |
| Sino Biopharmaceutical | 142.12B |
| Akeso | 122.24B |
| Sichuan Kelun-Biotech Biopharmaceutical | 113.38B |